DE69633389D1 - Type f botulinum toxin und seine verwendung - Google Patents
Type f botulinum toxin und seine verwendungInfo
- Publication number
- DE69633389D1 DE69633389D1 DE69633389T DE69633389T DE69633389D1 DE 69633389 D1 DE69633389 D1 DE 69633389D1 DE 69633389 T DE69633389 T DE 69633389T DE 69633389 T DE69633389 T DE 69633389T DE 69633389 D1 DE69633389 D1 DE 69633389D1
- Authority
- DE
- Germany
- Prior art keywords
- toxin
- type
- botulinum toxin
- fragment
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108030001720 Bontoxilysin Proteins 0.000 title 1
- 229940053031 botulinum toxin Drugs 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000007888 toxin activity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9511909.5A GB9511909D0 (en) | 1995-06-12 | 1995-06-12 | Vaccine |
| GB9511909 | 1995-06-12 | ||
| PCT/GB1996/001409 WO1996041881A1 (en) | 1995-06-12 | 1996-06-12 | Type f botulinum toxin and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69633389D1 true DE69633389D1 (de) | 2004-10-21 |
| DE69633389T2 DE69633389T2 (de) | 2005-10-27 |
Family
ID=10775930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69633389T Expired - Lifetime DE69633389T2 (de) | 1995-06-12 | 1996-06-12 | Type f botulinum toxin und seine verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7041792B2 (de) |
| EP (1) | EP0833919B1 (de) |
| JP (1) | JP4005633B2 (de) |
| AT (1) | ATE276366T1 (de) |
| AU (1) | AU705944B2 (de) |
| CA (1) | CA2224444C (de) |
| DE (1) | DE69633389T2 (de) |
| DK (1) | DK0833919T3 (de) |
| ES (1) | ES2224171T3 (de) |
| GB (1) | GB9511909D0 (de) |
| PT (1) | PT833919E (de) |
| WO (1) | WO1996041881A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214787B1 (en) * | 1993-09-21 | 2007-05-08 | United States Of America As Represented By The Secretary Of The Army | Recombinant vaccine against botulinum neurotoxin |
| DE19735105A1 (de) * | 1997-08-13 | 1999-03-04 | Univ Albert Ludwigs Freiburg | Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen |
| WO2000005252A1 (en) * | 1998-07-22 | 2000-02-03 | Agricultural Research Council | Vaccine comprising a non-toxic immunogenic derivative of clostridium botulinum type d neurotoxin |
| EP1180999A4 (de) * | 1999-05-12 | 2005-03-30 | Us Army Medical Res And Materi | Rekombinanter impfstoff gegen botulinum-neurotoxin |
| US20060073208A1 (en) * | 2004-10-01 | 2006-04-06 | Allergan, Inc. | Cosmetic neurotoxin compositions and methods |
| GB0525213D0 (en) * | 2005-12-12 | 2006-01-18 | Secr Defence | Vaccine |
| EP2907504B1 (de) | 2011-02-08 | 2017-06-28 | Halozyme, Inc. | Zusammensetzung und Lipidformulierung eines Hyaluronan-abbauenden Enzyms und seiner Verwendung zur Behandlung von benigner Prostatahyperplasie |
| KR102175159B1 (ko) * | 2018-12-28 | 2020-11-05 | 대한민국 | 재조합 벡터, 형질전환 대장균, 보툴리눔 d/c형 중쇄 c말단 유래의 재조합 단백질을 포함하는 백신 조성물 및 키트 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| US5736139A (en) * | 1989-10-31 | 1998-04-07 | Ochidian Pharmaceuticals, Inc. | Treatment of Clostridium difficile induced disease |
| KR950702635A (ko) | 1992-07-31 | 1995-07-29 | 크리스틴 헬렌 수덴 | 감쇠 박테리아에서 재조합 융합 단백질의 발현(Expression of recombinant fusion proteins in attenuated bacteria) |
| GB9305919D0 (en) * | 1993-03-22 | 1993-05-12 | Health Lab Service Board | Botulinum toxin polypeptides and their use as vaccines |
-
1995
- 1995-06-12 GB GBGB9511909.5A patent/GB9511909D0/en active Pending
-
1996
- 1996-06-12 DK DK96917600T patent/DK0833919T3/da active
- 1996-06-12 AT AT96917600T patent/ATE276366T1/de active
- 1996-06-12 PT PT96917600T patent/PT833919E/pt unknown
- 1996-06-12 EP EP96917600A patent/EP0833919B1/de not_active Expired - Lifetime
- 1996-06-12 WO PCT/GB1996/001409 patent/WO1996041881A1/en active IP Right Grant
- 1996-06-12 US US08/981,087 patent/US7041792B2/en not_active Expired - Fee Related
- 1996-06-12 CA CA2224444A patent/CA2224444C/en not_active Expired - Fee Related
- 1996-06-12 ES ES96917600T patent/ES2224171T3/es not_active Expired - Lifetime
- 1996-06-12 JP JP50279897A patent/JP4005633B2/ja not_active Expired - Fee Related
- 1996-06-12 AU AU60121/96A patent/AU705944B2/en not_active Ceased
- 1996-06-12 DE DE69633389T patent/DE69633389T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20020081304A1 (en) | 2002-06-27 |
| JP4005633B2 (ja) | 2007-11-07 |
| GB9511909D0 (en) | 1995-08-09 |
| AU705944B2 (en) | 1999-06-03 |
| CA2224444C (en) | 2010-02-16 |
| PT833919E (pt) | 2005-01-31 |
| ATE276366T1 (de) | 2004-10-15 |
| EP0833919B1 (de) | 2004-09-15 |
| CA2224444A1 (en) | 1996-12-27 |
| ES2224171T3 (es) | 2005-03-01 |
| DK0833919T3 (da) | 2005-01-17 |
| EP0833919A1 (de) | 1998-04-08 |
| JPH11507827A (ja) | 1999-07-13 |
| US7041792B2 (en) | 2006-05-09 |
| WO1996041881A1 (en) | 1996-12-27 |
| DE69633389T2 (de) | 2005-10-27 |
| AU6012196A (en) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974432A (fi) | Grampositiivisten bakteerien käyttö rekombinanttiproteiinien ilmentämiseksi | |
| IS4345A (is) | Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur | |
| BR9504791B1 (pt) | composto de polipeptìdeo e composição farmacêutica. | |
| DZ2086A1 (fr) | Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant. | |
| BR9607317A (pt) | Peptídios e composição farmacêutica | |
| BR9607318A (pt) | Peptidos e composição farmacêutica | |
| DE69434511D1 (de) | Botulinumtoxin zur Behandlung von Dystonie | |
| KR950700990A (ko) | 신규의 분비단백질 에프-스폰딘의 클로닝, 발현 및 용도 | |
| MA23895A1 (fr) | Amides therapeutiques et compositions les contenant | |
| DE69520088D1 (de) | Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten | |
| ATE476495T1 (de) | Bazillus thuringiensis und dessen insektizide proteine | |
| ATE397062T1 (de) | Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten | |
| DE69625506D1 (de) | Schwefelsubstituierte peptide als inhibitoren für metalloproteinasen und der tnf-freisetzung | |
| NO964758D0 (no) | Anvendelse av von Willebrand-faktor og farmasöytiske preparater | |
| ATE220688T1 (de) | Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen | |
| DE69633389D1 (de) | Type f botulinum toxin und seine verwendung | |
| FR2694296B1 (fr) | Peptides inhibant l'activité des protéines ras, préparation et utilisation. | |
| DE69530483D1 (de) | Modifizierendes produkt und modifizierende zusammensetzung für protein enthaltende substanz | |
| NO980296D0 (no) | Forbedrede terapeutiske midler | |
| DE19681439T1 (de) | Modifizierung von Polypeptidarzneimitteln zur Erhöhung des Elektrotransportflusses | |
| FR2732978B1 (fr) | Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes | |
| ES2089784T3 (es) | Expresion de estafilocinasas sin peptido de señal. | |
| FI953422A0 (fi) | Autolysoivia fuusioproteiineja hyväksikäyttävät ilmentämisjärjestelmät ja uusi pelkistävä polypeptidi | |
| DE69534596D1 (de) | Epil/plazentin | |
| DK75393D0 (da) | Production of protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: HEALTH PROTECTION AGENCY, SALISBURY, WILTSHIRE, GB |